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Abstract 
Analysis of the EEF1G/PPP6R3 fusion involving 
EEF1G (alias, eukaryotic translation elongation 
factor 1 gamma) gene and PPP6R3 (alias, protein 
phosphatase 6 regulatory subunit 3) gene. It was 
detected in lung squamous cell carcinoma. 
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Clinics and pathology 
Disease 
Lung squamous cell carcinoma 
Note 
Lung squamous cell carcinoma (lung SqCC) shows 
very complex genomic alterations with abundant 
exonic mutations, genomic rearrangements and gene 
copy number alterations.  
Some authors detected the presence of the 
EEF1G/PPP6R3 fusion deriving by the genomic 
translocation of a part of EEF1G gene with a portion 
of PPP6R3 gene, both located on chromosome 11 
(Hammerman et al., 2012). Other fusion genes or 
abnormal chromosomal translocations detected for 
PPP6R3 in  
this cancer type are t(7;11)(q21;q13) 
CCDC132/PPP6R3, t(7;11)(q34;q13) 
PPP6R3/MGAM, t(7;11)(q34;q13)SSBP1/PPP6R3, 
and fusion genes PPP6R3/ARHGAP1, 
PPP6R3/CNTN5, and PPP6R3/LRP5 (Yoshihara et 
al., 2015; Hammerman et al., 2012; 
http://www.tumorfusions.org) 
Prognosis 
There is no evidence of the impact of the 
EEF1G/PPP6R3 fusion gene on the tumour 
behaviour and so its contribution in the prognosis of 
lung squamous cell carcinoma is still unknown. 
Genes involved and 
proteins 
EEF1G 
Location 11q12.3 
Note 
Eukaryotic translation elongation factor 1 gamma, 
alias eEF1G, is a protein that play a main function in 
the elongation step of translation process but also 
cover numerous moonlighting roles.  
It is expressed ubiquitously in human tissues and 
often it is found over-expressed in human cancer 
samples and cancer cell lines. 
DNA / RNA 
EEF1G (Eukaryotic Translation Elongation Factor 1 
Gamma) is a protein coding gene with 10 exons and 
a length of 14388 bp (RefSeq  NC_000011.10). Its 
transcript is 1446 bp long (RefSeq NM_001404.5) 
but was observed five splice variants and nine 
pseudogenes probably originated by 
retrotransposition. 
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Protein 
eEF1G is formed by 437 amino acids (RefSeq 
NP_001395.1), it has a molecular weight of 50.12 
kDa and it is a multi-domain protein which consist 
of three main domains: from the amino to carboxyl 
half terminal there are a glutathione S-transferase 
(GST)-like N-terminus domain (NT-eEF1G), a 
glutathione S-transferase (GST)-like C-terminus 
domain (CT-eEF1G) and a conserved C-terminal 
domain (CD-eEF1G)(Achilonu et al.,2014).  
eEF1G is a subunit of the eukaryotic elongation 
factor-1 complex named eEF1H that result by the 
aggregation of different proteins that play a central 
role in peptide elongation during eukaryotic protein 
biosynthesis. The physiological role of eEF1G is still 
not well defined, however eEF1G seems to be 
necessary for guarantee the stability to entire eEF1H 
complex and to stimulate the activity of the eEF1B2 
subunit during the elongation step of translation 
(Mansilla et al., 2002). However, are known that it 
has multiple non-canonical roles (moonlighting 
roles) inside the cell such as the interaction with 
cytoskeleton and binding with various mRNA and 
several proteins, comprise membrane-bound 
receptors (Coumans et al., 2014; Corbi et al., 2010; 
Cho et al., 2003). 
PPP6R3 
Location 11q13.2 
DNA / RNA 
PPP6R3 is a protein coding gene of 154617 nt long  
(RefSeq NC_000011.10) and with an abundant 
number of alternative splicing variants, i.e. 38 
coding mRNA and 24 non-coding mRNA. 
Protein 
PPP6R3 counts 24 protein isoforms and is one of the 
three regulatory subunits of protein phosphatase 6 
(PP6) complex (York et al., 2014; Guergnon et al., 
2009) and has a sit4-associated protein domain, alias 
SAPS domain (Stefansson and Brautigan, 2006). It 
plays a role, as member of PP6 holoenzyme, in the 
turnover of serine and threonine phosphorylation 
events during mitosis acting as a regulatory element 
of the complex. 
Result of the chromosomal 
anomaly 
Hybrid Gene 
The result of chromosomal anomaly is the 
EEF1G/PPP6R3 fusion with the formation of a novel 
but not still characterized fusion gene 5' EEF1G - 3' 
PPP6R3.  Hammerman and colleagues 
(Hammerman et al., 2012) found it in patients with 
lung squamous cell carcinoma (lung SqCC), but 
there are no data or evidence about its mRNA and/or 
its protein. So, in this review, with the use of 
Ensembl (http://www.ensembl.org), will be 
predicted the result of this rearrangement. However, 
the data collected and showed are hypothesis and 
have to be experimentally verified. 
 
Figure 1. Schematic representation of the EEF1G gene, PPP6R3 gene and the EEF1G-PPP6R3 fusion.  [A] In the upper side of 
the picture there are the genomic sequences of EEF1G and PPP6R3 genes with the indication of DNA breakpoints individuated 
by Hammerman and colleagues (Hammerman et al., 2012); [B] in the bottom side of the picture are reported the genomic 
rearrangement on chromosome 11 and the predicted structure of the novel EEF1G/PPP6R3 fusion after the analysis with 
Ensembl (http://www.ensembl.org). In addition, there are also indicated the promoter/enhancer elements (reworked from 
https://www.genecards.org). 
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Description 
A EEF1G/PPP6R3 fusion was found in lung 
squamous cell carcinoma (lung SqCC) 
(Hammerman et al., 2012). Hammerman and 
colleagues (Hammerman et al., 2012) identified two 
DNA breakpoints that cause the EEF1G/PPP6R3 
fusion: the first is located at the position 62,323,148 
of the EEF1G gene, while the second is located at the 
position 68,368,269 of PPP6R3 (alias, SAPS3) gene, 
both upstream of the respective genes involved. In 
addition, Hammerman and colleagues (Hammerman 
et al., 2012) identified a novel fusion gene 5'EEF1G 
- 3'PPP6R3  derived by this abnormal translocation 
thus formed: at 5' fusion end there is a sequence 
starting from 4 kb before EEF1G gene while at 3' 
fusion end there is a sequence starting from 303 bp 
after exon 19 of PPP6R3 gene. However, the 
nucleotide sequence of this novel chimeric gene is 
not reported or registered anywhere and so it remains 
uncharacterized.  
From the direct analysis of the gene sequences and 
the respective DNA breakpoints using Ensembl 
(http://www.ensembl.org), could be advanced the 
hypothesis that the chromosomal rearrangement 
where EEF1G and PPP6R3 are involved, although it 
was described as an intra-chromosomal 
translocation, it seems more similar to an inversion. 
Moreover the first breakpoint is located 236,453 nt 
before EEF1G gene while the second breakpoint is 
located just before PPP6R3 gene, i.e. 92,441 nt 
before PPP6R3 gene (Figure.1). This chromosomal 
rearrangement permits to bring near EEF1G to 
PPP6R3, reducing the long distance between them, 
i.e. from 5,886,730 nt (about 5,886 kb) to only 
328,894 nt (about 328 kb). The reason of this 
rearrangement is unknown. 
Transcript 
There is no evidence about the mRNA of the 
EEF1G/PPP6R3 fusion gene or other transcript 
resulting from the EEF1G/PPP6R3. 
Fusion Protein 
Description 
There is no evidence of protein from the 
EEF1G/PPP6R3 fusion gene. 
Oncogenesis 
The role in oncogenesis of the EEF1G/PPP6R3 
fusion is unclear, and there is no evidence about its 
effective transcription and/or translation. 
Hammerman and colleagues (Hammerman et al., 
2012) have supposed the presence of a fusion gene 
5'EEF1G - 3'PPP6R3 but actually there are poor data 
about it and thus it is unclearly the role of this fusion 
gene, i.e. if is effectively translated into a functional 
protein or instead it plays a regulatory role. What it 
is clear is that PPP6R3 is involved in many and 
heterogeneous genomic translocations in different 
kind of tumors as EEF1G that is involved in 
numerous genomic alterations such as translocations 
and in novel fusion genes. Both genes are important 
for cell biology and it is normal that they are 
subjected to rearrangements in cancer cells. In 
addition, this could happens also for the 
characteristics of their promoters because at least for 
PPP6R3 it is known that it possess a potent promoter 
activity (Guo et al., 2016). However, the truly 
oncogenic potential of EEF1G/PPP6R3 in 
proliferation and cancer aggressiveness needs to be 
better elucidated. 
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